- Home
- AACG vs PMVP Comparison
AACG vs PMVP Comparison
Compare AACG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- PMVP
- Stock Information
- Founded
- AACG 1999
- PMVP 2013
- Country
- AACG China
- PMVP United States
- Employees
- AACG N/A
- PMVP N/A
- Industry
- AACG Other Consumer Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- AACG Real Estate
- PMVP Health Care
- Exchange
- AACG Nasdaq
- PMVP Nasdaq
- Market Cap
- AACG 65.1M
- PMVP 77.4M
- IPO Year
- AACG N/A
- PMVP 2020
- Fundamental
- Price
- AACG $2.51
- PMVP $1.23
- Analyst Decision
- AACG
- PMVP Strong Buy
- Analyst Count
- AACG 0
- PMVP 1
- Target Price
- AACG N/A
- PMVP $5.00
- AVG Volume (30 Days)
- AACG 77.4K
- PMVP 2.7M
- Earning Date
- AACG 11-06-2025
- PMVP 11-06-2025
- Dividend Yield
- AACG N/A
- PMVP N/A
- EPS Growth
- AACG N/A
- PMVP N/A
- EPS
- AACG N/A
- PMVP N/A
- Revenue
- AACG $39,064,701.00
- PMVP N/A
- Revenue This Year
- AACG N/A
- PMVP N/A
- Revenue Next Year
- AACG N/A
- PMVP N/A
- P/E Ratio
- AACG N/A
- PMVP N/A
- Revenue Growth
- AACG 15.19
- PMVP N/A
- 52 Week Low
- AACG $0.50
- PMVP $0.81
- 52 Week High
- AACG $2.58
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- AACG 66.97
- PMVP 42.42
- Support Level
- AACG $2.05
- PMVP $1.12
- Resistance Level
- AACG $2.58
- PMVP $1.35
- Average True Range (ATR)
- AACG 0.20
- PMVP 0.17
- MACD
- AACG 0.02
- PMVP -0.03
- Stochastic Oscillator
- AACG 91.67
- PMVP 15.16
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.